Civic Intelligence

Nick Gilbert Neurofibromatosis

EIN 99-3110088 • 501(c)3 • Detroit, MI

Profile

The principal purpose of the institute is to actively and continuously engage directly in the conduct of medical research, both on its own and in conjunction with one or more hospitals and universities. The institute has begun its initial efforts in scientific and medical research to accelerate the development of research findings and technologies that will lead to the creation of new medicines, new diagnostics, and other enabling products to treat patients with neurofibromatosis ("nf") and other debilitating neuronal diseases and related conditions. In the current year, the institute has established research partnerships and began construction on its operational space.

1074 Woodward AvenueDetroit, MI 48226

www.ngnri.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

60th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2024

Liabilities / Revenue

62nd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2024

Net Margin

98th percentile

100%

Higher net margin than 98% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2024

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2024

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2024

Assets

$149,999

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Net Assets

$149,999

No earlier filing loaded for comparison.

Revenue

$150,000

No earlier filing loaded for comparison.

Expenses

$1

No earlier filing loaded for comparison.

Net Income

$149,999

No earlier filing loaded for comparison.

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$150K$100K$50K$0Assets 2024: $149,999Liabilities 2024: $0Net Assets 2024: $149,9992024

Highlighted filing

2024

Assets$149,999
Liabilities$0
Net Assets$149,999

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$150K$100K$50K$0Revenue 2024: $150,000Expenses 2024: $1Net Income 2024: $149,9992024

Highlighted filing

2024

Revenue$150,000
Expenses$1
Net Income$149,999

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$1.50$0.00$1.50$1.50$0.00$1.50
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Nov 6, 2025
Return Version
2024v5.2
Gross Receipts
$150,000
Mission and Program Overview

Mission

The principal purpose of the institute is to actively and continuously engage directly in the conduct of medical research, both on its own and in conjunction with one or more hospitals and universities. The institute has begun its initial efforts in scientific and medical research to accelerate the development of research findings and technologies that will lead to the creation of new medicines, new diagnostics, and other enabling products to treat patients with neurofibromatosis ("nf") and other debilitating neuronal diseases and related conditions. In the current year, the institute has established research partnerships and began construction on its operational space.

Program Services

DescriptionGrantsExpenses
THE PRINCIPAL PURPOSE OF THE INSTITUTE IS TO ACTIVELY AND CONTINUOUSLY ENGAGE DIRECTLY IN THE CONDUCT OF MEDICAL RESEARCH, BOTH ON ITS OWN AND IN CONJUNCTION WITH ONE OR MORE HOSPITALS AND UNIVERSITIES. THE INSTITUTE HAS BEGUN ITS INITIAL EFFORTS IN SCIENTIFIC AND MEDICAL RESEARCH TO ACCELERATE THE DEVELOPMENT OF RESEARCH FINDINGS AND TECHNOLOGIES THAT WILL LEAD TO THE CREATION OF NEW MEDICINES, NEW DIAGNOSTICS, AND OTHER ENABLING PRODUCTS TO TREAT PATIENTS WITH NEUROFIBROMATOSIS ("NF") AND OTHER DEBILITATING NEURONAL DISEASES AND RELATED CONDITIONS. IN THE CURRENT YEAR, THE INSTITUTE HAS ESTABLISHED RESEARCH PARTNERSHIPS AND BEGAN CONSTRUCTION ON ITS OPERATIONAL SPACE.$0$0
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
LAURA GRANNEMANNPresident, Director-$0--
JEFFREY MORGANROTHSecretary, Director-$0--
MATTHEW RIZIKTreasurer, Director-$0--
DANIEL GILBERTDirector-$0--
JENNIFER GILBERTDirector-$0--
Filing and Contact Details

Filer

Filer Name
Nick Gilbert Neurofibromatosis
EIN
99-3110088
Phone
3133733977
Address
1074 WOODWARD AVENUE, DETROIT, MI 48226

Signing Officer

Name
Matthew J Rizik
Title
Treasurer
Phone
3133733977
Signed
2025-11-06
Discuss with paid preparer
Yes

Preparer

Firm
Plante & Moran Pllc
Address
8181 E TUFTS AVE SUITE 600, DENVER, CO 80237
Preparer
Dori J Eggett
Phone
3037409400
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16 - Other Expenses

Description: miscellaneous expense. Amount: 1.

Raw XML Appendix140 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/ApplicationPendingInd0X
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0MATTHEW RIZIK
IRS990EZ/BooksInCareOfDetail/PhoneNum03137829500
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt01074 WOODWARD AVENUE
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0DETROIT
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MI
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd0482261906
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt00
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0149999
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/ContributionsGiftsGrantsEtcAmt0150000
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt0149999
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt00
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0149999
IRS990EZ/GrossReceiptsAmt0150000
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/InitialReturnInd0X
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt00
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0149999
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt00
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0149999
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt00.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt10.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt20.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt30.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt40.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0LAURA GRANNEMANN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1JEFFREY MORGANROTH
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2MATTHEW RIZIK
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3DANIEL GILBERT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4JENNIFER GILBERT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PRESIDENT, DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1SECRETARY, DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2TREASURER, DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4DIRECTOR
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt01
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0THE PRINCIPAL PURPOSE OF THE INSTITUTE IS TO ACTIVELY AND CONTINUOUSLY ENGAGE DIRECTLY IN THE CONDUCT OF MEDICAL RESEARCH, BOTH ON ITS OWN AND IN CONJUNCTION WITH ONE OR MORE HOSPITALS AND UNIVERSITIES. THE INSTITUTE HAS BEGUN ITS INITIAL EFFORTS IN SCIENTIFIC AND MEDICAL RESEARCH TO ACCELERATE THE DEVELOPMENT OF RESEARCH FINDINGS AND TECHNOLOGIES THAT WILL LEAD TO THE CREATION OF NEW MEDICINES, NEW DIAGNOSTICS, AND OTHER ENABLING PRODUCTS TO TREAT PATIENTS WITH NEUROFIBROMATOSIS ("NF") AND OTHER DEBILITATING NEURONAL DISEASES AND RELATED CONDITIONS. IN THE CURRENT YEAR, THE INSTITUTE HAS ESTABLISHED RESEARCH PARTNERSHIPS AND BEGAN CONSTRUCTION ON ITS OPERATIONAL SPACE.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0THE PRINCIPAL PURPOSE OF THE INSTITUTE IS TO ACTIVELY AND CONTINUOUSLY ENGAGE DIRECTLY IN THE CONDUCT OF MEDICAL RESEARCH, BOTH ON ITS OWN AND IN CONJUNCTION WITH ONE OR MORE HOSPITALS AND UNIVERSITIES. THE INSTITUTE HAS BEGUN ITS INITIAL EFFORTS IN SCIENTIFIC AND MEDICAL RESEARCH TO ACCELERATE THE DEVELOPMENT OF RESEARCH FINDINGS AND TECHNOLOGIES THAT WILL LEAD TO THE CREATION OF NEW MEDICINES, NEW DIAGNOSTICS, AND OTHER ENABLING PRODUCTS TO TREAT PATIENTS WITH NEUROFIBROMATOSIS ("NF") AND OTHER DEBILITATING NEURONAL DISEASES AND RELATED CONDITIONS. IN THE CURRENT YEAR, THE INSTITUTE HAS ESTABLISHED RESEARCH PARTNERSHIPS AND BEGAN CONSTRUCTION ON ITS OPERATIONAL SPACE.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt00
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/SchoolOperatingInd00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0MI
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt00
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt00
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt01
IRS990EZ/TotalProgramServiceExpensesAmt00
IRS990EZ/TotalRevenueAmt0150000
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.NGNRI.ORG
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm0DETROIT
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd0MI
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt0HENRY FORD HEALTH
IRS990ScheduleA/MedicalResearchOrganizationInd0X
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DESCRIPTION: MISCELLANEOUS EXPENSE. AMOUNT: 1.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES
TransferPrsnlBnftContractsDecl/DeclarationDesc0THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0MATTHEW J RIZIK
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0TREASURER
ReturnHeader/BusinessOfficerGrp/PhoneNum03133733977
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-11-06
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0NICK GILBERT NEUROFIBROMATOSIS
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0RESEARCH INSTITUTE
ReturnHeader/Filer/BusinessNameControlTxt0NICK
ReturnHeader/Filer/EIN0993110088
ReturnHeader/Filer/PhoneNum03133733977
ReturnHeader/Filer/USAddress/AddressLine1Txt01074 WOODWARD AVENUE
ReturnHeader/Filer/USAddress/CityNm0DETROIT
ReturnHeader/Filer/USAddress/StateAbbreviationCd0MI
ReturnHeader/Filer/USAddress/ZIPCd048226
ReturnHeader/IRSResponsiblePrtyInfoCurrInd01
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0331498605
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0PLANTE & MORAN PLLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt08181 E TUFTS AVE SUITE 600
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0DENVER
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CO
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd080237
ReturnHeader/PreparerPersonGrp/PhoneNum03037409400
ReturnHeader/PreparerPersonGrp/PreparationDt02025-11-06
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0DORI J EGGETT
ReturnHeader/ReturnTs02025-11-13T14:25:53-06:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.